Retour
Prix Stella Diagnostics Inc (SLDX)
Graphique du cours de l'action SLDX
SLDX Gagner
Stella Diagnostics Inc
$0.01
0%
$0
À la fermeture : Feb 06, 16:00:00 GMT-5
$0.01
0%
$0
Post-Marché: Feb 06, 20:00:00 GMT-5
Pas encore de donnéesEarnings FAQ
Comment le bénéfice par action récent de SLDX se compare-t-il aux attentes ?
Comment les revenus de Stella Diagnostics Inc SLDX se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Stella Diagnostics Inc ?
Quel est le score de qualité des bénéfices pour Stella Diagnostics Inc ?
Quand Stella Diagnostics Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Stella Diagnostics Inc ?
Stella Diagnostics Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.0154
Prix d'ouverture
$0.014
Plage de la journée
$0.014 - $0.0154
Plage de 52 semaines
$0.0111 - $0.0585
Volume
20
Volume moyen
543
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
$1.5M
Qu’est-ce que SLDX ?
Stella Diagnostics, Inc. operates as a molecular diagnostics-based organization, which focuses on improving patient management strategies. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2003-07-29. The Company’s proprietary technology is based on rigorous research by domain experts and practicing physicians and can notify providers if common diseases of the esophagus like GERD and Barrett’s esophagus express proteins associated with normal or carcinogenic processes. Its panel of biomarkers and targeted proteomics method, the company can better inform gastroenterologists, surgical oncologists and pathologists which patients are high risk for disease progression into precancer or cancer. The predictive panel will be offered as a Laboratory Developed Test (LDT) in a CAP/CLIA Certified moderate complexity laboratory. Its subsidiaries include SLDX, Inc. and Galaxy Pharmaceuticals LLC.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved